Drugs in development as of January 2008 for the treatment of actinic keratosis, melanoma, andpsoriasis
Selected websites
http://www.aad.org/
American Academy of Dermatology
http://www.nlm.nih.gov/medlineplus/psoriasis.html
MedlinePlus health information on psoriasis
http://www.niams.nih.gov/
National Institute of Arthritis and Musculoskeletal and Skin Diseases
http://www.psoriasis.org/
National Psoriasis Foundation
Payers Recognize the Benefits, but Still See Weight Loss Drugs through a Cost Lens
April 12th 2024Jeffrey Casberg, M.S., R.Ph., a senior vice president of clinical pharmacy at IPD Analytics LLC, a drug intelligence firm that advises payers and pharmaceutical companies, talks about how payers are thinking about weight-loss drugs.
Drugs to Watch: Mental Health Conditions
April 11th 2024The FDA is reviewing two novel therapies: a psychedelic-assisted therapy for PTSD with a target action date of Aug. 11, 2024, and therapy for schizophrenia that does not directly block dopamine receptors with an action date of Sept. 26, 2024.